REFERENCES
1. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718-23.
2. Valsecchi C, Carlotta Tagliacarne S, Castellazzi A. Gut microbiota and obesity. J Clin Gastroenterol. 2016;50:S157-8.
3. Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr. 2011;6:241-60.
4. Anand S, Mande SS. Host-microbiome interactions: gut-liver axis and its connection with other organs. NPJ Biofilms Microbiomes. 2022;8:89.
5. Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238.
6. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979-84.
7. Ellekilde M, Selfjord E, Larsen CS, et al. Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Sci Rep. 2014;4:5922.
8. Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr. 2013;56:461-8.
9. Zheng C, Wan M, Guo Q, Duan Y, Yin Y. Glutamate increases the lean percentage and intramuscular fat content and alters gut microbiota in Shaziling pigs. Anim Nutr. 2025;20:110-9.
10. Wang F, Feng J, Yao M, et al. Dietary succinate reduces fat deposition through gut microbiota and lipid metabolism in broilers. Poult Sci. 2024;103:103954.
11. Wang L, Zhou J, Gober HJ, et al. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2021;133:110958.
12. Cui X, Gou Z, Jiang Z, et al. Dietary fiber modulates abdominal fat deposition associated with cecal microbiota and metabolites in yellow chickens. Poult Sci. 2022;101:101721.
13. Breton J, Galmiche M, Déchelotte P. Dysbiotic gut bacteria in obesity: an overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms. 2022;10:452.
14. Guzzardi MA, La Rosa F, Iozzo P. Trust the gut: outcomes of gut microbiota transplant in metabolic and cognitive disorders. Neurosci Biobehav Rev. 2023;149:105143.
15. Houtman TA, Eckermann HA, Smidt H, de Weerth C. Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Sci Rep. 2022;12:3140.
16. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070-5.
17. May KS, den Hartigh LJ. Modulation of adipocyte metabolism by microbial short-chain fatty acids. Nutrients. 2021;13:3666.
18. Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. Front Endocrinol. 2022;13:1025706.
19. Kieffer DA, Piccolo BD, Marco ML, et al. Mice fed a high-fat diet supplemented with resistant starch display marked shifts in the liver metabolome concurrent with altered gut bacteria. J Nutr. 2016;146:2476-90.
20. Zhang L, Ouyang Y, Li H, et al. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial. Sci Rep. 2019;9:4736.
21. Cho KY. Association of gut microbiota with obesity in children and adolescents. Clin Exp Pediatr. 2023;66:148-54.
22. Wang G, Chen X, Sun C, et al. Gut microbiota and metabolite insights into anti-obesity effect of carboxymethyl pachymaran in high-fat diet mice. J Funct Foods. 2023;111:105898.
23. Yin J, Li Y, Tian Y, et al. Obese Ningxiang pig-derived microbiota rewires carnitine metabolism to promote muscle fatty acid deposition in lean DLY pigs. Innovation. 2023;4:100486.
24. Li C, Zhao X, Zhao G, et al. Comparative analysis of structural composition and function of intestinal microbiota between Chinese indigenous Laiwu Pigs and commercial DLY Pigs. Vet Sci. 2023;10:524.
25. Yang M, Xie Q, Wang J, et al. Ningxiang pig-derived lactobacillus reuteri modulates host intramuscular fat deposition via branched-chain amino acid metabolism. Microbiome. 2025;13:32.
26. Bergamaschi M, Tiezzi F, Howard J, et al. Gut microbiome composition differences among breeds impact feed efficiency in swine. Microbiome. 2020;8:110.
27. Shang P, Wei M, Duan M, Yan F, Chamba Y. Healthy gut microbiome composition enhances disease resistance and fat deposition in Tibetan Pigs. Front Microbiol. 2022;13:965292.
28. Luo Y, Ren W, Smidt H, et al. Dynamic distribution of gut microbiota in pigs at different growth stages: composition and contribution. Microbiol Spectr. 2022;10:e0068821.
29. Wu C, Lyu W, Hong Q, Zhang X, Yang H, Xiao Y. Gut microbiota influence lipid metabolism of skeletal muscle in pigs. Front Nutr. 2021;8:675445.
30. Wen C, Yan W, Sun C, et al. The gut microbiota is largely independent of host genetics in regulating fat deposition in chickens. ISME J. 2019;13:1422-36.
31. Chen Y, Akhtar M, Ma Z, et al. Chicken cecal microbiota reduces abdominal fat deposition by regulating fat metabolism. NPJ Biofilms Microbiomes. 2023;9:28.
32. Liu X, Wang C, Wang Y, et al. Age-associated changes in the growth development of abdominal fat and their correlations with cecal gut microbiota in broiler chickens. Poult Sci. 2023;102:102900.
33. Liu Y, Yang J, Liu X, et al. Dietary folic acid addition reduces abdominal fat deposition mediated by alterations in gut microbiota and SCFA production in broilers. Anim Nutr. 2023;12:54-62.
34. Liu X, Wang C, Li Y, et al. Fecal microbiota transplantation revealed the function of folic acid on reducing abdominal fat deposition in broiler chickens mediated by gut microbiota. Poult Sci. 2024;103:103392.
35. Nan S, Yao M, Zhang X, et al. Fermented grape seed meal promotes broiler growth and reduces abdominal fat deposition through intestinal microorganisms. Front Microbiol. 2022;13:994033.
36. Dai H, Gao J, Zhang Y, et al. Dietary phytosterols supplementation improves the growth performance and decreases the abdominal fat of broiler chickens by regulating intestinal epithelial structure and microbiota. Anim Feed Sci Technol. 2023;305:115786.
37. Zhang Y, Liu Y, Li J, et al. Dietary corn-resistant starch suppresses broiler abdominal fat deposition associated with the reduced cecal Firmicutes. Poult Sci. 2020;99:5827-37.
38. Wu T, Wang P, Fu Q, et al. Effects of dietary supplementation of Anoectochilus roxburghii extract (ARE) on growth performance, abdominal fat deposition, meat quality, and gut microbiota in broilers. Poult Sci. 2023;102:102842.
39. Xiao L, Liu J, Qin L, et al. Multi-omics reveal the effects and regulatory mechanism of dietary echinocystic acid supplementation on abdominal fat and liver steatosis in broiler chickens. Poult Sci. 2025;104:104981.
40. Wang M, Ma W, Wang C, Li D.
41. Jing Y, Yuan Y, Monson M, et al. Multi-omics association reveals the effects of intestinal microbiome-host interactions on fat deposition in broilers. Front Microbiol. 2021;12:815538.
42. Liu J, Wang J, Zhou Y, et al. Integrated omics analysis reveals differences in gut microbiota and gut-host metabolite profiles between obese and lean chickens. Poult Sci. 2022;101:102165.
43. Lei J, Dong Y, Hou Q, et al. Intestinal microbiota regulate certain meat quality parameters in chicken. Front Nutr. 2022;9:747705.
44. Xiang H, Gan J, Zeng D, et al. Specific microbial taxa and functional capacity contribute to chicken abdominal fat deposition. Front Microbiol. 2021;12:643025.
45. He J, Zhang P, Shen L, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci. 2020;21:6356.
46. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-71.
47. den Besten G, Bleeker A, Gerding A, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64:2398-408.
48. Xiao S, Zhang Z, Chen M, et al. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism. J Ethnopharmacol. 2019;241:112032.
49. Wang L, Zhang S, Huang Y, Zhou Y, Shan T. Conjugated linoleic acids inhibit lipid deposition in subcutaneous adipose tissue and alter lipid profiles in serum of pigs. J Anim Sci. 2023;101:skad294.
50. di Gregorio MC, Cautela J, Galantini L. Physiology and physical chemistry of bile acids. Int J Mol Sci. 2021;22:1780.
51. Dong Z, Yang S, Tang C, Li D, Kan Y, Yao L. New insights into microbial bile salt hydrolases: from physiological roles to potential applications. Front Microbiol. 2025;16:1513541.
52. Li R, Andreu-Sánchez S, Kuipers F, Fu J. Gut microbiome and bile acids in obesity-related diseases. Best Pract Res Clin Endocrinol Metab. 2021;35:101493.
53. Finn PD, Rodriguez D, Kohler J, et al. Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice. Am J Physiol Gastrointest Liver Physiol. 2019;316:G412-24.
54. Lun W, Yan Q, Guo X, et al. Mechanism of action of the bile acid receptor TGR5 in obesity. Acta Pharm Sin B. 2024;14:468-91.
55. Pols TW, Nomura M, Harach T, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 2011;14:747-57.
56. Boutagy NE, McMillan RP, Frisard MI, Hulver MW. Metabolic endotoxemia with obesity: is it real and is it relevant? Biochimie. 2016;124:11-20.
57. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72.
58. Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020;11:594150.
59. Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel TJ, Van Eck M. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr Drug Targets. 2011;12:647-60.
60. Gojda J, Cahova M. Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules. 2021;11:1414.
61. Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12:35.
62. Daniel N, Nachbar RT, Tran TTT, et al. Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice. Nat Commun. 2022;13:1343.
63. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y. Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem. 1999;274:19745-51.
64. Wallace M, Green CR, Roberts LS, et al. Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues. Nat Chem Biol. 2018;14:1021-31.
65. Green CR, Wallace M, Divakaruni AS, et al. Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat Chem Biol. 2016;12:15-21.
66. Zaganjor E, Yoon H, Spinelli JB, et al. SIRT4 is an early regulator of branched-chain amino acid catabolism that promotes adipogenesis. Cell Rep. 2021;36:109345.
67. Yoneshiro T, Wang Q, Tajima K, et al. BCAA catabolism in brown fat controls energy homeostasis through SLC25A44. Nature. 2019;572:614-9.
68. Ejtahed HS, Angoorani P, Soroush AR, Hasani-Ranjbar S, Siadat SD, Larijani B. Gut microbiota-derived metabolites in obesity: a systematic review. Biosci Microbiota Food Health. 2020;39:65-76.
69. Mansoori S, Ho MY, Ng KK, Cheng KK. Branched-chain amino acid metabolism: pathophysiological mechanism and therapeutic intervention in metabolic diseases. Obes Rev. 2025;26:e13856.
70. Van Hul M, Cani PD. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat Rev Endocrinol. 2023;19:258-71.
71. Nemoto S, Kubota T, Ohno H. Exploring body weight-influencing gut microbiota by elucidating the association with diet and host gene expression. Sci Rep. 2023;13:5593.
72. Velloso LA, Folli F, Saad MJ. TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev. 2015;36:245-71.
73. Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep. 2015;4:250-61.
74. Ecklu-Mensah G, Choo-Kang C, Maseng MG, et al. Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study. Nat Commun. 2023;14:5160.
75. Visuthranukul C, Sriswasdi S, Tepaamorndech S, et al. Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity. Int J Obes. 2024;48:1696-704.
76. Slouha E, Rezazadah A, Farahbod K, Gerts A, Clunes LA, Kollias TF. Type-2 diabetes mellitus and the gut microbiota: systematic review. Cureus. 2023;15:e49740.
77. Zeng Y, Wu Y, Zhang Q, Xiao X. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio. 2024;15:e0203223.
78. Wu J, Yang K, Fan H, Wei M, Xiong Q. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Front Endocrinol. 2023;14:1114424.
79. Hernández-Montoliu L, Rodríguez-Peña MM, Puig R, et al. A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass. Front Endocrinol. 2023;14:1181744.
80. Byndloss M, Devkota S, Duca F, et al. The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetes Care. 2024;47:1491-508.
81. Cui X, Chen J, Yang Y. Administration of selenomethionine in combination with serine benefits diabetes via gut microbiota. Front Microbiol. 2022;13:1007814.
82. Su X, Chen S, Liu J, et al. Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Obes Rev. 2024;25:e13646.
83. Zai W, Chen W, Liu H, Ju D. Therapeutic opportunities of IL-22 in non-alcoholic fatty liver disease: from molecular mechanisms to clinical applications. Biomedicines. 2021;9:1912.
84. Maestri M, Santopaolo F, Pompili M, Gasbarrini A, Ponziani FR. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies. Front Nutr. 2023;10:1110536.
85. Pezzino S, Sofia M, Mazzone C, et al. Gut microbiome in the progression of NAFLD, NASH and cirrhosis, and its connection with biotics: a bibliometric study using dimensions scientific research database. Biology. 2023;12:662.
86. Liu J, Wu A, Cai J, She ZG, Li H. The contribution of the gut-liver axis to the immune signaling pathway of NAFLD. Front Immunol. 2022;13:968799.
87. Alveirinho M, Freitas P, Faleiro ML. Role of gut microbiota in metabolic syndrome: a review of recent evidence. Porto Biomed J. 2020;5:e105.
88. Qureshi W, Dar MA, Rather MY. New therapy for metabolic syndrome: gut microbiome supplementation. World J Diabetes. 2024;15:1833-6.
89. Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14.
90. Nakai M, Ribeiro RV, Stevens BR, et al. Essential hypertension is associated with changes in gut microbial metabolic pathways: a multisite analysis of ambulatory blood pressure. Hypertension. 2021;78:804-15.
91. Li C, Cheng D, Ren H, Zhang T. Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health. Front Endocrinol. 2025;16:1529703.
92. Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. 2025;23:443.
